do the kind glp 1 patches really work GLP-1 And Are They Safe? Doctors Weigh In GLP-1 Patches Exposed: Do They

Dual-pathway therapies that target both GLP-1 and GIP receptors sit alongside better-known GLP-1-focused options

GLP-1s affect metabolism, digestion, and appetite

In both patient populations with pre-existing cardiovascular disease, DPP-4 inhibitors are recommended as one possible third-line therapy besides SGLT-2 inhibitors, thiazolidinediones, or insulin, when therapeutic goals are not met with the previous dual combination

But losing more than 1.5%2% of body weight per week raises the risk of muscle and bone loss

These drugs should be used cautiously or avoided in patients with a history of pancreatitis, those with certain rare thyroid cancers (such as medullary thyroid carcinoma), patients with severe gastrointestinal disorders, and pregnant or breastfeeding women

In particular, clinically relevant fibrosis is detectable in about 15% of diabetic patients [95]